Literature DB >> 10568570

Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease.

L Y Chang1, T Y Lin, K H Hsu, Y C Huang, K L Lin, C Hsueh, S R Shih, H C Ning, M S Hwang, H S Wang, C Y Lee.   

Abstract

BACKGROUND: In Taiwan, from April to July, 1998, an epidemic of hand, foot, and mouth disease associated with enterovirus 71 (EV71) occurred with fatal complications. We did a clinical study of EV71-related diseases in Taiwan.
METHODS: We studied 154 children with virus-culture confirmed EV71 infection. Children were divided into three groups: 11 patients with pulmonary oedema; 38 patients with central nervous system (CNS) involvement and no pulmonary oedema; and 105 children without complications. We compared the clinical features, laboratory findings, risk factors, and outcome among these three groups.
FINDINGS: Nine children with pulmonary oedema had hand, foot, and mouth disease, one had herpangina, and one had febrile illness with eight children with limb weakness and one with limb hypesthesia. All children had had sudden onset of tachycardia, tachypnoea, and cyanosis 1-3 days after onset of the disease. Nine of 11 children died within 12 h of intubation; one child was braindead within 15 h and died 17 days after intubation; one child was in deep coma and died 3 months later. In children with CNS complication and no pulmonary oedema, one child died of pneumonia after 4 months of ventilator support and four children had sequelae. All 105 children without complications recovered. There was a significant association between CNS involvement and pulmonary oedema (odds ratio 12.4 [95% CI 2.6-60.1], p=0.001). Risk factors for pulmonary oedema after CNS involvement were hyperglycaemia, leucocytosis, and limb weakness. Hyperglycaemia was the most significant prognostic factor for pulmonary oedema (odds ratio 21.5 [3-159], p=0.003).
INTERPRETATION: EV71 can cause hand, foot, and mouth disease, CNS involvement with severe sequelae, and fatal pulmonary oedema. Hyperglycaemia is the most important prognostic factor.

Entities:  

Mesh:

Year:  1999        PMID: 10568570     DOI: 10.1016/S0140-6736(99)04434-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  153 in total

1.  Prolonged exclusive breastfeeding, autumn birth and increased gestational age are associated with lower risk of fever in children with hand, foot, and mouth disease.

Authors:  Q Zhu; Y Li; N Li; Q Han; Z Liu; Z Li; J Qiu; G Zhang; F Li; N Tian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

2.  Development of a transcription-reverse transcription concerted reaction method for specific detection of human enterovirus 71 from clinical specimens.

Authors:  Naoto Nakajima; Yuka Kitamori; Satoru Ohnaka; Yasutami Mitoma; Katsumi Mizuta; Takaji Wakita; Hiroyuki Shimizu; Minetaro Arita
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

3.  Diverse apoptotic pathways in enterovirus 71-infected cells.

Authors:  Shih-Cheng Chang; Jing-Yi Lin; Lily Yen-cheng Lo; Mei-Ling Li; Shin-Ru Shih
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

4.  Quantitative PCR-enhanced immunoassay for measurement of enteroviral immunoglobulin M antibody and diagnosis of aseptic meningitis.

Authors:  Amal Elfaitouri; Nahla Mohamed; Jan Fohlman; Robert Aspholm; Gun Frisk; Göran Friman; Lars Magnius; Jonas Blomberg
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

Review 5.  How to understand the efficacy measurements for enterovirus type 71 vaccine?

Authors:  Jing-Xin Li; Fan-Yue Meng; Zheng-Lun Liang; Qun-Ying Mao; Feng-Cai Zhu
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

6.  Optimization of a Class of Tryptophan Dendrimers That Inhibit HIV Replication Leads to a Selective, Specific, and Low-Nanomolar Inhibitor of Clinical Isolates of Enterovirus A71.

Authors:  Eva Rivero-Buceta; Liang Sun; Belén Martínez-Gualda; Elisa G Doyagüez; Kim Donckers; Ernesto Quesada; María-José Camarasa; Leen Delang; Ana San-Félix; Johan Neyts; Pieter Leyssen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

7.  Identification of genes involved in the host response to enterovirus 71 infection.

Authors:  Shin-Ru Shih; Victor Stollar; Jing-Yi Lin; Shih-Cheng Chang; Guang-Wu Chen; Mei-Ling Li
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

8.  Association of CD14 rs2569190 G/A genetic polymorphism with the severity of enterovirus 71 infection in Chinese children.

Authors:  Ya Guo; Yedan Liu; Jie Song; Peipei Liu; Sifei Wu; Yuxia Tan; Fan Fan; Zongbo Chen
Journal:  Virology       Date:  2020-06-07       Impact factor: 3.616

9.  The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.

Authors:  Chun Shi Jia; Jiang Ning Liu; Wan Bo Li; Chun Mei Ma; Shu Zhu Lin; Yi Hao; Xue Zhong Gao; Xiao Lin Liu; Yan Feng Xu; Lian Feng Zhang; Chuan Qin
Journal:  Virol J       Date:  2010-02-22       Impact factor: 4.099

10.  Fatal case of enterovirus 71 infection, France, 2007.

Authors:  Sophie Vallet; Marie Christine Legrand Quillien; Thomas Dailland; Gaëtan Podeur; Stéphanie Gouriou; Isabelle Schuffenecker; Christopher Payan; Pascale Marcorelles
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.